Next Article in Journal
Rescue of Hepatic Phospholipid Remodeling Defect in iPLA2β-Null Mice Attenuates Obese but Not Non-Obese Fatty Liver
Next Article in Special Issue
Anti-BCMA Immunotoxins: Design, Production, and Preclinical Evaluation
Previous Article in Journal
Allosteric Inhibition of Adenylyl Cyclase Type 5 by G-Protein: A Molecular Dynamics Study
Previous Article in Special Issue
Development of Recombinant Immunotoxins for Hairy Cell Leukemia
Open AccessFeature PaperReview

Targeting Receptors on Cancer Cells with Protein Toxins

Biotherapy Section, Laboratory of Molecular Biology, Center of Cancer Research, National Cancer Institute, NIH., 37 Convent Dr, Room 5124, Bethesda, MD 20892, USA
Authors to whom correspondence should be addressed.
Biomolecules 2020, 10(9), 1331;
Received: 21 July 2020 / Revised: 12 September 2020 / Accepted: 16 September 2020 / Published: 17 September 2020
(This article belongs to the Special Issue Immunotoxins: From Design to Clinical Application)
Cancer cells frequently upregulate surface receptors that promote growth and survival. These receptors constitute valid targets for intervention. One strategy involves the delivery of toxic payloads with the goal of killing those cancer cells with high receptor levels. Delivery can be accomplished by attaching a toxic payload to either a receptor-binding antibody or a receptor-binding ligand. Generally, the cell-binding domain of the toxin is replaced with a ligand or antibody that dictates a new binding specificity. The advantage of this “immunotoxin” approach lies in the potency of these chimeric molecules for killing cancer cells. However, receptor expression on normal tissue represents a significant obstacle to therapeutic intervention. View Full-Text
Keywords: toxin; immunotoxin; diphtheria; pseudomonas; ricin; receptor; cancer toxin; immunotoxin; diphtheria; pseudomonas; ricin; receptor; cancer
Show Figures

Figure 1

MDPI and ACS Style

Antignani, A.; Ho, E.C.H.; Bilotta, M.T.; Qiu, R.; Sarnvosky, R.; FitzGerald, D.J. Targeting Receptors on Cancer Cells with Protein Toxins. Biomolecules 2020, 10, 1331.

AMA Style

Antignani A, Ho ECH, Bilotta MT, Qiu R, Sarnvosky R, FitzGerald DJ. Targeting Receptors on Cancer Cells with Protein Toxins. Biomolecules. 2020; 10(9):1331.

Chicago/Turabian Style

Antignani, Antonella; Ho, Eric C.H.; Bilotta, Maria T.; Qiu, Rong; Sarnvosky, Robert; FitzGerald, David J. 2020. "Targeting Receptors on Cancer Cells with Protein Toxins" Biomolecules 10, no. 9: 1331.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop